Detalhe da pesquisa
1.
Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment.
Metabolites
; 13(1)2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36677048
2.
Therapeutic Stimulation of Glycolytic ATP Production for Treating ROS-Mediated Cellular Senescence.
Metabolites
; 12(12)2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36557198
3.
Oxygen therapy in traditional and immunotherapeutic treatment protocols of cancer patients: current reality and future prospects.
Expert Rev Anticancer Ther
; 22(6): 575-581, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468308
4.
Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses.
Arthritis Rheum
; 62(12): 3656-65, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20862679
5.
Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
J Allergy Clin Immunol
; 126(5): 1006-15, 1015.e1-4, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20934207
6.
Clinically feasible and prospective immunotherapeutic interventions in multidirectional comprehensive treatment of cancer.
Expert Opin Biol Ther
; 21(3): 323-342, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981358
7.
Profound invariant natural killer T-cell deficiency in inflammatory arthritis.
Ann Rheum Dis
; 69(10): 1873-9, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20444757
8.
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.
J Leukoc Biol
; 85(2): 243-50, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18971286
9.
Immune memory limits human longevity: the role of memory СD4+ T cells in age-related immune abnormalities.
Expert Rev Vaccines
; 19(3): 209-215, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32191535
10.
Immunotherapy for treating metastatic colorectal cancer.
Surg Oncol
; 21(2): 67-77, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21292476
11.
Invariant natural killer T (iNKT) cell deficiency in chronic mucocutaneous candidiasis--a consequence or a cause?
Immunol Lett
; 135(1-2): 180-3, 2011 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20923687
12.
Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis.
Arthritis Rheum
; 62(1): 143-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20039419
13.
T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice.
Ann Rheum Dis
; 66(5): 599-604, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17114189
14.
The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
Arthritis Rheum
; 54(2): 482-91, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16447222
15.
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice.
Arthritis Res Ther
; 8(4): R93, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16704744
16.
Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.
Immunology
; 119(3): 385-92, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16919002
17.
Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.
Immunology
; 114(2): 194-203, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15667564
18.
Localization of peptide/MHC class II complexes in macrophages following antigen processing of viable Streptococcus pyogenes.
Eur J Immunol
; 33(9): 2353-60, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12938211
19.
Regulation of peptide presentation by major histocompatibility complex class II molecules at the surface of macrophages.
Eur J Immunol
; 33(12): 3359-66, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14635044
20.
The route of bacterial uptake by macrophages influences the repertoire of epitopes presented to CD4 T cells.
Eur J Immunol
; 32(12): 3714-9, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12516565